Cosmos Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COSM research report →
About the company
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace.
- CEO
- Grigorios Siokas
- IPO
- 2010
- Employees
- 149
- HQ
- Chicago, IL, US
Price Chart
- Market Cap
- $14.72M
- P/E
- -0.36
- P/S
- 0.21
- P/B
- 0.56
- EV/EBITDA
- -1.90
- Div Yield
- 0.00%
- Gross Margin
- 10.40%
- Op Margin
- -25.75%
- Net Margin
- -30.41%
- ROE
- -96.48%
- ROIC
- -45.73%
- Revenue
- $65.27M · 19.93%
- Net Income
- $-19,144,998 · -18.30%
- EPS
- $-0.63 · 46.15%
- Op Income
- $-16,540,819
- FCF YoY
- -4.53%
- 52W High
- $1.32
- 52W Low
- $0.16
- 50D MA
- $0.27
- 200D MA
- $0.52
- Beta
- 4.15
- Avg Volume
- 6.67M
Get TickerSpark's AI analysis on COSM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | Terzis Georgios | buy | 168,135 |
| Jun 11, 26 | Siokas Grigorios | buy | 218,447 |
| Jun 10, 26 | Siokas Grigorios | buy | 701,447 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 20,000 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 35,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
| May 19, 26 | Demetriades Demetrios G. | other | 20,000 |
| May 19, 26 | Demetriades Demetrios G. | other | 20,000 |
| May 19, 26 | Aslidis Anastasios | other | 40,000 |
Our COSM coverage
Recent articles, reports, and earnings notes.
No research on COSM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COSM report →Similar companies
Peers in the same neighborhood.